Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$9.77M |
| 2 |
T. Rowe Price
TROW
|
+$8.5M |
| 3 |
Adobe
ADBE
|
+$7.78M |
| 4 |
Salesforce
CRM
|
+$6.86M |
| 5 |
Biogen
BIIB
|
+$3.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$9.52M |
| 2 |
General Dynamics
GD
|
+$7.03M |
| 3 |
Lockheed Martin
LMT
|
+$2.44M |
| 4 |
RTX Corp
RTX
|
+$1.98M |
| 5 |
Wells Fargo
WFC
|
+$1.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.59% |
| 2 | Technology | 13.8% |
| 3 | Communication Services | 12.18% |
| 4 | Consumer Staples | 12.09% |
| 5 | Financials | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
iShares Russell 1000 Value ETF
IWD
$84.2B
| – | – |
-154
| Closed | -$26K |
|
52
iShares Russell 1000 Growth ETF
IWF
$125B
| – | – |
-212
| Closed | -$16K |
|
53
iShares Russell 2000 Value ETF
IWN
$14.6B
| – | – |
-17
| Closed | -$3K |
|
54
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| – | – |
-33
| Closed | -$4K |
|
55
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
| – | – |
-44
| Closed | -$5K |
|
56
Coca-Cola
KO
$392B
| – | – |
-9,106
| Closed | -$539K |
|
|
57
Lockheed Martin
LMT
$130B
| – | – |
-6,862
| Closed | -$2.44M |
|
58
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| – | – |
-2,591
| Closed | -$1.23M |
|
|
59
ExxonMobil
XOM
$679B
| – | – |
-155,605
| Closed | -$9.52M |
|
Similar funds
Mark Hillman's Q1 2022 Portfolio in Review
As of Q1 2022, Mark Hillman held 59 positions worth $315M, up 8.3% from $291M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Mark Hillman deployed $24.2M of net new capital in Q1 2022, opening 5 new positions and adding to 36 existing holdings. Its largest new stake was ASML: 14,591 shares worth $9.74M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was RTX Corp, an estimated $1.98M trimmed.
- Mark Hillman's largest Q1 2022 buy was ASML: 14,591 shares worth $9.74M.
- Mark Hillman added most to Salesforce in Q1 2022, an estimated $6.86M increase.
- Mark Hillman's biggest Q1 2022 reduction was RTX Corp, cutting an estimated $1.98M.
- Mark Hillman fully exited ExxonMobil in Q1 2022, selling an estimated $9.52M.
- Mark Hillman's ten largest holdings make up 32% of its $315M portfolio in Q1 2022.
- Mark Hillman opened 5 new positions and closed 11 in Q1 2022.
- Mark Hillman's portfolio value rose 8.3% quarter-over-quarter to $315M.
Based on Hillman Capital Management's 13F filing for Q1 2022, filed 16 May 2022.